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. Measured pre-and postnatal serum PCB and DDE concentrations in relation to 6-month BCGspecific IgG and IgA levels. Table S2 . Serum PCB concentration estimated using a PBPK model in relation to 6-month BCG-specific IgG and IgA levels. Table S3 . Serum DDE concentration estimated using a PBPK model in relation to 6-month BCG-specific IgG and IgA levels. Table S4 . Median 6-month BCG-specific antibody levels by categories of 6-month infant PCB and DDE exposures, with contrasts between each exposure category (n=454). The primary model includes adjustment for maternal ethnicity, education, and age, with 6-month PCB and DDE concentration expressed on a lipid basis. The first model is identical to the primary model except that PCB and DDE concentrations are expressed on a ng/ml basis, and 6-month infant lipid concentration is entered as a covariate. The second model adds covariates maternal smoking, parity, district of residence, child sex, and child age at 6-month blood draw. The third model adds a categorical variable for BCG ELISA batch date to the primary model. The fourth model adds an indicator variable to the primary model for high-resolution gas chromatography with electron capture detection versus highresolution mass spectrometry. The fifth model removes the top and bottom 3% of the respective 6-month infant serum PCB or DDE concentrations. The final sensitivity analysis combines all the previous sensitivity model specifications. Figure S1 : Unadjusted dose-response relation between quartiles of maternal serum PCB and DDE concentrations and mean 6-month BCG-specific IgG (Panels A and B) and IgA (Panels C and D) levels, across the serum dilution range. identical to the primary model except that PCB and DDE concentrations are expressed on a ng/ml basis, and 6-month infant lipid concentration is entered as a covariate. The second model adds covariates maternal smoking, parity, district of residence, child sex, and child age at 6-month blood draw. The third model adds a categorical variable for BCG ELISA batch date to the primary model. The fourth model adds an indicator variable to the primary model for high-resolution gas chromatography with electron capture detection versus high-resolution mass spectrometry. The fifth model removes the top and bottom 3% of the respective 6-month infant serum PCB or DDE concentrations. The final sensitivity analysis combines all the previous sensitivity model specifications.
